About Annoviant
Founded in 2018, Annoviant is a cardiovascular device company developing next-generation regenerative implants that improve durability, reduce complications, and promote natural tissue remodeling.
The company is backed by leading healthcare institutions, research organizations, established vendors, incubator programs, FDA-funded consortia, NIH grants, and private capital.
The Clinical Challenge
Fathom Science delivers cutting-edge ocean intelligence by combining artificial intelligence with physics-based ocean, weather, and wave modeling.
Our platform creates a real-time digital twin of the ocean, providing hyperlocal, high-fidelity forecasts for marine conditions anywhere in the world.
We solve critical forecasting challenges for maritime industries, enabling better decisions in:
Nearly one-third of U.S. children enter kindergarten without foundational skills needed to thrive (NCES, 2022). These early gaps widen over time—by third grade, reading proficiency predicts high-school graduation with 90% accuracy, and children who struggle by age nine are four times more likely to leave school without a diploma.
Vocalis Care is a healthcare communication company dedicated to eliminating language barriers at the bedside.
Our core product is a mobile app that enables real-time, context-aware communication between clinicians and patients who do not share a language. Designed specifically for hospital and clinic use on hospital-issued devices, it ensures medically relevant and culturally appropriate interactions when clarity is most critical.
Aspira Medical is a medical device company developing a first-of-its-kind wearable ultrasound platform designed to continuously monitor gastric distension in critically ill patients and prevent aspiration pneumonia—one of the leading causes of morbidity, mortality, and extended ICU stays.
SelSym Biotech is a preclinical-stage company focused on improving survivability after severe hemorrhage—the leading cause of death in populations under 45, both domestically and globally.
Most trauma-related deaths occur early due to ineffective bleeding interventions. Current options are limited:
EndoLimb Orthoplastic Solutions, Inc. is advancing the EndoThumb, a transformative implantable device designed to address the significant unmet need in thumb amputation reconstruction.
Thumb amputation causes profound disability—the thumb accounts for:
Atomistic Insights is an AI-driven drug discovery platform that makes previously intractable targets druggable by addressing a core limitation in small-molecule discovery: reliance on static protein structures.
Clarus Labs commercializes a kinetic, light-based testing platform that transforms slow, lab-bound chemical analysis into rapid, on-site quantification.
Our first product delivers oxidation testing for meat and pet food in under 10 minutes, replacing traditional assays that require skilled chemists, expensive instruments, and hours of processing.
VibraPower is an energy technology startup developing resonance-tracking vibration energy harvesters that convert wasted mechanical vibrations into continuous electrical power for wireless sensors.
Our mission is to eliminate batteries and wiring in industrial monitoring systems, enabling self-powered, maintenance-free sensors that power the next generation of AI-enabled industrial intelligence.
